MK-1064 is a selective and orally active OX 2 R antagonist ( K i : 0.5 nM, IC 50 : 18 nM). MK-1064 promotes sleep in vivo . MK-1064 can be used in the research of insomnia.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Endocrinology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Orexin Receptor (OX Receptor)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.